Skip to main content
. 2018 Jan 11;12:137–148. doi: 10.2147/DDDT.S148457

Figure 5.

Figure 5

Effects of LY294002 on AKT and p-AKT expression of hPDLCs. (A) The increased expression of osteogenic marker proteins can be interdicted by PI3K pathway inhibitor LY294002 in hPDLCs. The expression level of ALP and Runx2 was tested by Western blot (B) and RT-PCR (C). *P<0.05, **P<0.01.

Abbreviations: IP, ipriflavone; ALP, alkaline phosphatase; hPDLCs, human periodontal ligament cells; RT-PCR, real-time polymerase chain reaction; LY, LY294002.